Sullivan Lara has filed 16 insider transactions across 1 company since January 2023.
Most recent transaction: a grant/award of 918308 shares of Pyxis Oncology, Inc. ($PYXS) on March 31, 2025.
Activity breakdown: 0 open-market purchases and 5 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 31, 2025 | Pyxis Oncology, Inc. | $PYXS | Sullivan Lara | President ,CEO & CMO | A | Stock Option (Right to Buy) | 918308 | $0.98 | 918,308.0000 | 58,445,765 | 9999.99% | 1.57% |
| Dec. 23, 2024 | Pyxis Oncology, Inc. | $PYXS | Sullivan Lara | Chief Executive Officer | A | Stock Option (Right to Buy) | 1135000 | $0.00 | 1,135,000.0000 | 60,715,041 | 9999.99% | 1.87% |
| March 26, 2024 | Pyxis Oncology, Inc. | $PYXS | Sullivan Lara | Chief Executive Officer | A | Stock Option (Right to Buy) | 1071242 | $3.83 | 1,071,242.0000 | 39,904,603 | 9999.99% | 2.68% |
| Sept. 14, 2023 | Pyxis Oncology, Inc. | $PYXS | Sullivan Lara | President and CEO | S | Common Stock | 100 | $2.25 | 2,412,423.0000 | 0 | 0.00% | 0.00% |
| Sept. 18, 2023 | Pyxis Oncology, Inc. | $PYXS | Sullivan Lara | President and CEO | S | Common Stock | 8541 | $2.10 | 2,403,882.0000 | 0 | 0.35% | 0.00% |
| Sept. 11, 2023 | Pyxis Oncology, Inc. | $PYXS | Sullivan Lara | President and CEO | S | Common Stock | 20000 | $2.27 | 2,605,182.0000 | 0 | 0.76% | 0.00% |
| Sept. 12, 2023 | Pyxis Oncology, Inc. | $PYXS | Sullivan Lara | President and CEO | S | Common Stock | 4917 | $2.25 | 2,600,265.0000 | 0 | 0.19% | 0.00% |
| Sept. 13, 2023 | Pyxis Oncology, Inc. | $PYXS | Sullivan Lara | President and CEO | S | Common Stock | 3000 | $2.27 | 2,597,265.0000 | 0 | 0.12% | 0.00% |
| Sept. 13, 2023 | Pyxis Oncology, Inc. | $PYXS | Sullivan Lara | President and CEO | F | Common Stock | 184742 | $2.13 | 2,412,523.0000 | 0 | 7.11% | 0.00% |
| Sept. 7, 2023 | Pyxis Oncology, Inc. | $PYXS | Sullivan Lara | President and CEO | A | Common Stock | 469483 | $0.00 | 2,625,182.0000 | 0 | 21.78% | 0.00% |
| March 24, 2023 | Pyxis Oncology, Inc. | $PYXS | Sullivan Lara | President and CEO | A | Common Stock | 703379 | $0.00 | 2,155,699.0000 | 0 | 48.43% | 0.00% |
| March 24, 2023 | Pyxis Oncology, Inc. | $PYXS | Sullivan Lara | President and CEO | D | Stock Option (Right to buy) | 990461 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| March 24, 2023 | Pyxis Oncology, Inc. | $PYXS | Sullivan Lara | President and CEO | D | Stock Option (Right to buy) | 61825 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| March 24, 2023 | Pyxis Oncology, Inc. | $PYXS | Sullivan Lara | President and CEO | A | Stock Option (Right to buy) | 990461 | $0.00 | 990,461.0000 | 0 | 9999.99% | 0.00% |
| March 24, 2023 | Pyxis Oncology, Inc. | $PYXS | Sullivan Lara | President and CEO | A | Stock Option (Right to buy) | 61825 | $0.00 | 61,825.0000 | 0 | 9999.99% | 0.00% |
| Jan. 3, 2023 | Pyxis Oncology, Inc. | $PYXS | Sullivan Lara | Chief Executive Officer | A | Common Stock | 95684 | $0.00 | 1,452,320.0000 | 0 | 7.05% | 0.00% |